EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS022-13247 
Organism
Homo sapiens 
Tissue/cell
CD4+ 
Coordinate
chr8:28257700-28260900 
TF binding sites/motifs
Number: 40             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
EWSR1-FLI1MA0149.1chr8:28259755-28259773GGGAGGAGGGAGGGAGGG+6.03
EWSR1-FLI1MA0149.1chr8:28259854-28259872GGAGGGAGAGAAGGAGGG+6.03
EWSR1-FLI1MA0149.1chr8:28259874-28259892GGAGGGAGAGAAGGAGGG+6.03
EWSR1-FLI1MA0149.1chr8:28259332-28259350CCCTCCCTCCCTCCCTCC-6.03
EWSR1-FLI1MA0149.1chr8:28259862-28259880AGAAGGAGGGGAGGAGGG+6.2
EWSR1-FLI1MA0149.1chr8:28259842-28259860GGAGGGAGGGGAGGAGGG+6.34
EWSR1-FLI1MA0149.1chr8:28259815-28259833GGAAGGAAGGAAAGAGAG+7.37
KLF5MA0599.1chr8:28259467-28259477GCCCCGCCCC+6.02
KLF5MA0599.1chr8:28259529-28259539GCCCCGCCCC+6.02
KLF5MA0599.1chr8:28259940-28259950GGGGCGGGGC-6.02
ZNF263MA0528.1chr8:28259851-28259872GGAGGAGGGAGAGAAGGAGGG+10.09
ZNF263MA0528.1chr8:28259871-28259892GGAGGAGGGAGAGAAGGAGGG+10.09
ZNF263MA0528.1chr8:28259906-28259927AAAGCAGGGGAGGGGGAAGGG+6.09
ZNF263MA0528.1chr8:28259831-28259852AGTGGAGGGGCGGAGGGAGGG+6.15
ZNF263MA0528.1chr8:28259771-28259792GGGGGAGGGGTAGATGGGGAG+6.31
ZNF263MA0528.1chr8:28259785-28259806TGGGGAGGAGGGAGGGAGGAG+6.34
ZNF263MA0528.1chr8:28259716-28259737GGTGGAGAGAAGAGGGGAGGA+6.38
ZNF263MA0528.1chr8:28259836-28259857AGGGGCGGAGGGAGGGGAGGA+6.3
ZNF263MA0528.1chr8:28259742-28259763GAGGGAGGAGGTGGGGAGGAG+6.48
ZNF263MA0528.1chr8:28259802-28259823GGAGGAGGGACAGGGAAGGAA+6.56
ZNF263MA0528.1chr8:28259839-28259860GGCGGAGGGAGGGGAGGAGGG+6.59
ZNF263MA0528.1chr8:28259860-28259881AGAGAAGGAGGGGAGGAGGGA+6.5
ZNF263MA0528.1chr8:28259341-28259362CCTCCCTCCCGCCCCACCTCC-6.72
ZNF263MA0528.1chr8:28259764-28259785GAGGGAGGGGGGAGGGGTAGA+6.76
ZNF263MA0528.1chr8:28259734-28259755GGAGGAGGGAGGGAGGAGGTG+6.78
ZNF263MA0528.1chr8:28259753-28259774TGGGGAGGAGGGAGGGAGGGG+6.79
ZNF263MA0528.1chr8:28259738-28259759GAGGGAGGGAGGAGGTGGGGA+6.89
ZNF263MA0528.1chr8:28259911-28259932AGGGGAGGGGGAAGGGGAAAG+6.92
ZNF263MA0528.1chr8:28259843-28259864GAGGGAGGGGAGGAGGGAGAG+6.97
ZNF263MA0528.1chr8:28259748-28259769GGAGGTGGGGAGGAGGGAGGG+7.06
ZNF263MA0528.1chr8:28259728-28259749AGGGGAGGAGGAGGGAGGGAG+7.15
ZNF263MA0528.1chr8:28259745-28259766GGAGGAGGTGGGGAGGAGGGA+7.33
ZNF263MA0528.1chr8:28259760-28259781GAGGGAGGGAGGGGGGAGGGG+7.46
ZNF263MA0528.1chr8:28259848-28259869AGGGGAGGAGGGAGAGAAGGA+7.63
ZNF263MA0528.1chr8:28259868-28259889AGGGGAGGAGGGAGAGAAGGA+7.63
ZNF263MA0528.1chr8:28259863-28259884GAAGGAGGGGAGGAGGGAGAG+7.78
ZNF263MA0528.1chr8:28259788-28259809GGAGGAGGGAGGGAGGAGGAG+7.79
ZNF263MA0528.1chr8:28259799-28259820GGAGGAGGAGGGACAGGGAAG+7.98
ZNF263MA0528.1chr8:28259731-28259752GGAGGAGGAGGGAGGGAGGAG+8.28
ZNF263MA0528.1chr8:28259756-28259777GGAGGAGGGAGGGAGGGGGGA+9.49
Number of super-enhancer constituents: 27             
IDCoordinateTissue/cell
SE_00229chr8:28255250-28262078Adipose_Nuclei
SE_09976chr8:28255478-28260818CD14
SE_10881chr8:28255172-28272037CD20
SE_14002chr8:28257331-28258847CD34_Primary_RO01536
SE_14002chr8:28258909-28259726CD34_Primary_RO01536
SE_14002chr8:28259781-28261125CD34_Primary_RO01536
SE_17678chr8:28257238-28261225CD4p_CD25-_CD45RAp_Naive
SE_24655chr8:28258198-28260517Colon_Crypt_2
SE_26645chr8:28257250-28260912Esophagus
SE_27701chr8:28257858-28261004Fetal_Intestine
SE_28577chr8:28258026-28261038Fetal_Intestine_Large
SE_30513chr8:28257314-28261042Fetal_Muscle
SE_31606chr8:28257277-28260867Gastric
SE_36706chr8:28257941-28259351HMEC
SE_40988chr8:28257374-28260812Left_Ventricle
SE_42550chr8:28257572-28260838Lung
SE_48797chr8:28257261-28260697Right_Atrium
SE_50770chr8:28257241-28260963Sigmoid_Colon
SE_52497chr8:28257253-28260822Small_Intestine
SE_53710chr8:28257295-28261051Spleen
SE_55734chr8:28255502-28261747u87
SE_58644chr8:28219872-28277477Ly1
SE_59813chr8:28219869-28277603Ly4
SE_61002chr8:28174118-28277761HBL1
SE_61739chr8:28219999-28279573Toledo
SE_62508chr8:28220381-28270893Tonsil
SE_67509chr8:28255502-28261747u87
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 2             
ChromosomeStartEnd
chr82825852828258941
chr82825991528260405
Enhancer Sequence
AAGAAGTGAT AGCTGTGGCC AGCACCCAAT TTCCATTATT CTTTGAGGGA TAAATAAATA 60
CCACCGTGCC AAACTTATTA GTCAGGCCTG TTTTTGGAGA CAAGTGACAG GAACTGAATT 120
CATGCTAGCT TAAGCAAAAA AAATGAACTT GTTAGCTTCC TTAACTGGGA AACTCAGGAG 180
TATAACTGGC CCCAGGCACA GCACGACCCT GGGTTTAAAC AAAGTTGGTA GGGTCTGTTC 240
TCTAAATCTC TCATTTCTGG TTTGCTCCTT CATATCAGTC CCATTTTTTC CTACTTCAAA 300
AGAGCCCCCA GCCCTCAAAA ATGAGCTTCC CTCGTGCACT TGGGAACATG GCTGCTGGCA 360
GCTCCCAGCT ATGACATCCT AATTTAGCAG CACCAGCAGA AAACAAATTT TTCTCTCGCA 420
CATTCATATA TTAGTTCCAG GGAAAGACTG TAATTGATTC TGCTCAGTGA AAACGCTCAC 480
CCTTTGGACC GCTGTTGCCA GAGATGGAAT CCTACGGTGG CCAGCCCAAA AAAAACCACA 540
GGGAATAGAG AAGTGAGGTC CCATAGGAAG GGATGCGGGA CAGAGAAAAT CACATATGTC 600
CATTACACGA GGGAGAAGGG ACACCTTTGA GAGTCAAAGG ACACGTGCAC TTTCACTAGC 660
TGTGCGACCT CTGACAAACC GCTTTGCCTT TCTCAGCCTC CGTTCCTCAG GTGCAAAACG 720
GTTACCTGGG TGGTTATTAA GACATTACCA AGTTACGTGT CACAGCGTCT CTCTACTCTG 780
GATTTCTCAG ATAATGGAAA ACTGACTTCG TGGAGGAAGG CACCGCAACT GAGCCTGCTG 840
TCCTCAGTGT TCATGCAGAT ACCCTCGTGG AGCGCTCCAC GGTTTACGGA AAACTCTTGC 900
ATCGACTGCA TAAATTAGAA AATGAAGCGT AGGAGGCCAG ACTGCCTAGA GTACAGACTC 960
AGATCAGCTT AGTGCGTGAC TGGAGTCTCA TGCAGGCACA CAAACCATAG GGCGATGCTG 1020
CCACCGAGTC ATTTCCTGGA TTAGGAGAAG TGGCAGAGAC GCCCTCAGGG ACCACACGTG 1080
TCAGATCTCC ACCTCCCAAG CAGCGTTGCC CGGACGCGCC GCTCGGGGCC CAGAGCGCTG 1140
CGTGCACGCA GCCTCTAGCA ACCACTTACC GCGTGTGTGC GCATGTGTGT ACGTGTGTGT 1200
GCACGTGTGT ATATGTGTAG GTGCACGCAG GCGTGTGCGC GAGTGTGTGT ACGTGTGTGT 1260
ACACGCGTGT ATATGTGTGG GTGCGCGAGT GTGTATGTGT GTGACGCGTG TGTACGTGTG 1320
TATGCGCACG TGTGAGTGCA CTCGGGTGTA TGTGCTTGTG TGCACGCGCG CGTGTGTATC 1380
CGTGTGTGTG CGCGTGTATT TGTGCATGTG TGAGCGCGCC CGTGTGTGCA CGCATGTGTG 1440
TACGTATGTG TGTCGTGTGT GCGCGCGTGT ATGTGCGTGT GTGCGCACTC GGGGGTGTAC 1500
GTGTGAGTGC GCGCGCGCAC GCGTGTCTGT GTGTGTGGCA TGGGAGGTGG GCGGCAAGGA 1560
AAGCAGGCGA GACATTTTTT AAATAAAATA AGAAAAATAA AAGCCCAGCC TTCCAGGGCG 1620
TCTTCAGCCA GCCCCTCCCT CCCTCCCTCC CGCCCCACCT CCGGCTCCGG GGCCGCGGCT 1680
CCGGCGCCGC GTTTTCCCGG CCGCCCCGCG CCCGAGGGTT AAAGCTCCCC CGCCAGGAGT 1740
AAACAGCACC CCAGTCGGCA GCCGGCAGCC CCGCCCCTCG GCCCGTTTCC TGCGCCAGCC 1800
CTGGCAACAG GCCCCGCCCT TCGCGACAAG CCCCGCCCCG CGCCATCCGT CTGGCCCTTC 1860
CTGGCGTCCG CCTACTAGCG GCGGGGTCCC GGCCCGTGCC GAGTGCCCAG CCAGCCCCAA 1920
CCCTCTTCCC CCGGGATTCT GCGGCCAGAG CCCCAGCCGA GGGAGGGTGC GTGCCGCGCA 1980
CGTGACTCTT GTTGTAGGCG GGGCCTGCGC AGCGTCGGTG GAGAGAAGAG GGGAGGAGGA 2040
GGGAGGGAGG AGGTGGGGAG GAGGGAGGGA GGGGGGAGGG GTAGATGGGG AGGAGGGAGG 2100
GAGGAGGAGG GACAGGGAAG GAAGGAAAGA GAGTGGAGGG GCGGAGGGAG GGGAGGAGGG 2160
AGAGAAGGAG GGGAGGAGGG AGAGAAGGAG GGGAGGGACG GAGGGGAAAG CAGGGGAGGG 2220
GGAAGGGGAA AGCAGGGGAA GGGGCGGGGC GAGGGTCTGG CCTAGTCTCC TCCAGCTTCG 2280
TGGAGCCCGC CTGGGGCGCC GCTCTCCCGC CCCCGCCCCT CCACGGGTCC AGCTGGGAAC 2340
TGGCTATGGC CTCGCCGCCC GGCGAGGGCT GCAGTGGGTT CCCCGACGAC TTTGCCGCGG 2400
TTGCTGCTTC TGCCAGCGCA GCCTCGGAGC GCTGCCCGGC TGCAGGGCTC TCACCTCTTC 2460
CCCAGGTCCC TGCTCAGCAG AGCCTCTTAA GCTTCCTGCC TGTGTCCACA GAACCCGACA 2520
TCTCAAGCCC CCTGAACGCA CAGGCTCCTG CTGCATAAAC ACCCCGCCCT CCTGCCTCCT 2580
GCACACACAG GCCTACATTG TAGGGCCTCC CACGCCTCTC CGTTCCTGGA ATGGAGCTCA 2640
CCTAACCCTG TGCTCGTCCT GCTGTCTTCT CTAAGGGTGG GGAAACTTGA GGTTCAGAAA 2700
GCTGGAAGGA TTTCAGTGTG CACCATACAT CGACCACACA ACAGTCCCAC TCCTAGGTAT 2760
TACCCAAGAG AAATTAAAAC AGATGCCCAC ACTAAGACTT CTACGTGCAT CACAGCCAAC 2820
CAGAAAATAA TCACAATATC TGTGAACAGG AAAGTGAATA ACCAAATTGC AATATACCCA 2880
TGCAATGGAA CGCTACTCAA TAAAAAGAAA TAAACTTCTG ATGCAGTCAC TACCTGGGAG 2940
GAACCTCAGA AGTATTCGCT CTGGTGGACC CGGCACAGTG GCCCACCATT GTAATCCCAA 3000
CACTTTGGGA GGCCAAGGTA GGAGATCACT TGAGGCCAGG AGTTTGAGAC CAGCCTGGGC 3060
AACATAGTGA GACACCCCCC TCAACAACCC GCATCTCTTC AAAAATTAGA AAAATTAGCC 3120
AGGCATGGTG GTGCAGTCCT GTATTCTCAG CTGCTGGAGA GGCTGAGGTG GGTGGATCAC 3180
TTGAACACAG AAGTTCAAAG 3200